Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

OBJECTIVE We sought to evaluate performance of a noninvasive prenatal test for fetal trisomy 21 (T21) and trisomy 18 (T18). STUDY DESIGN A multicenter cohort study was performed whereby cell-free DNA from maternal plasma was analyzed. Chromosome-selective sequencing on chromosomes 21 and 18 was performed with reporting of an aneuploidy risk (High Risk or Low Risk) for each subject. RESULTS Of the 81 T21 cases, all were classified as High Risk for T21 and there was 1 false-positive result among the 2888 normal cases, for a sensitivity of 100% (95% confidence interval [CI], 95.5-100%) and a false-positive rate of 0.03% (95% CI, 0.002-0.20%). Of the 38 T18 cases, 37 were classified as High Risk and there were 2 false-positive results among the 2888 normal cases, for a sensitivity of 97.4% (95% CI, 86.5-99.9%) and a false-positive rate of 0.07% (95% CI, 0.02-0.25%). CONCLUSION Chromosome-selective sequencing of cell-free DNA and application of an individualized risk algorithm is effective in the detection of fetal T21 and T18.

[1]  K. Nicolaides,et al.  Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. , 2012, American journal of obstetrics and gynecology.

[2]  Wade A. Barrett,et al.  Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy , 2012, Prenatal diagnosis.

[3]  S. Norton,et al.  A new methodology to preserve the original proportion and integrity of cell‐free fetal DNA in maternal plasma during sample processing and storage , 2010, Prenatal diagnosis.

[4]  H. Cuckle,et al.  Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. , 2012, Obstetrics and gynecology.

[5]  H. White,et al.  Noninvasive prenatal testing for aneuploidy-ready for prime time? , 2012, American journal of obstetrics and gynecology.

[6]  Arnold Oliphant,et al.  Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[7]  Stanley F. Nelson,et al.  DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study , 2012, Genetics in Medicine.

[8]  C. Struble,et al.  Non‐invasive prenatal testing with cell‐free DNA: US physician attitudes toward implementation in clinical practice , 2013, Prenatal diagnosis.

[9]  ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. , 2007, Obstetrics and gynecology.

[10]  K. Nicolaides,et al.  Fetal Fraction in Maternal Plasma Cell-Free DNA at 11–13 Weeks’ Gestation: Effect of Maternal and Fetal Factors , 2012, Fetal Diagnosis and Therapy.

[11]  R. Rava,et al.  Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing , 2012, Obstetrics and gynecology.

[12]  A. Rudnicka,et al.  First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, New England Journal of Medicine.

[13]  Mohammad R Fotoohabadi,et al.  Effectiveness of a multifaceted podiatry intervention to prevent falls in community dwelling older people with disabling foot pain: randomised controlled trial , 2011, BMJ : British Medical Journal.

[14]  K. Nicolaides.  Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. , 2004, American journal of obstetrics and gynecology.

[15]  Stanley F. Nelson,et al.  Dna Sequencing of Maternal Plasma to Detect Down Syndrome: An International Clinical Validation Study , 2012 .

[16]  ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. , 2007, Obstetrics and gynecology.

[17]  E. B. Wilson.  Probable Inference, the Law of Succession, and Statistical Inference , 1927 .

[18]  Lin Tang,et al.  Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. , 2011, American journal of obstetrics and gynecology.

[19]  L. Dugoff,et al.  Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011 , 2012, Prenatal diagnosis.

[20]  Argyro Syngelaki,et al.  Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[21]  J. Queenan.  Exploring contraceptive options for breastfeeding mothers. , 2012, Obstetrics and gynecology.

[22]  Yama W. L. Zheng,et al.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.

[23]  Hepburn Pf,et al.  Private practice-3. , 1981 .

[24]  A. Caughey,et al.  Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[25]  R. Rava,et al.  837: LBA1 genome wide fetal aneuploidy detection by sequencing of maternal plasma DNA: diagnostic accuracy in a prospective, blinded, multicenter study , 2012 .

[26]  C. Cantor,et al.  Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. , 2011, American journal of obstetrics and gynecology.

[27]  Peiyong Jiang,et al.  Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing , 2011, PloS one.

[28]  J. Egan,et al.  Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists. , 2009, American journal of obstetrics and gynecology.

[29]  Tze Kin Lau,et al.  Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. , 2008, Clinical chemistry.

[30]  L. Shulman.  One small step and one giant leap for noninvasive prenatal screening: an editorial. , 2011, American journal of obstetrics and gynecology.

[31]  Y. Ville,et al.  Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. , 2006, American journal of obstetrics and gynecology.

[32]  J. Dungan,et al.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011 .